![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 11
Zeitschriftenartikel
Shad, Christina 
ORCID: https://orcid.org/0000-0002-0583-8350; Paal, Michael ORCID: https://orcid.org/0000-0001-8831-0238; Habler, Katharina ORCID: https://orcid.org/0000-0002-5110-346X; Scherf-Clavel, Oliver; Breuling, Magdalena; Berger, Christiane ORCID: https://orcid.org/0000-0003-4121-6687 und Naehrig, Susanne
(2025):
Therapeutic drug monitoring of elexacaftor, tezacaftor, and ivacaftor before, during, and after pregnancy in women with cystic fibrosis: An observational study.
In: Respiratory Medicine, Bd. 236, 107868
ORCID: https://orcid.org/0000-0002-0583-8350; Paal, Michael ORCID: https://orcid.org/0000-0001-8831-0238; Habler, Katharina ORCID: https://orcid.org/0000-0002-5110-346X; Scherf-Clavel, Oliver; Breuling, Magdalena; Berger, Christiane ORCID: https://orcid.org/0000-0003-4121-6687 und Naehrig, Susanne
(2025):
Therapeutic drug monitoring of elexacaftor, tezacaftor, and ivacaftor before, during, and after pregnancy in women with cystic fibrosis: An observational study.
In: Respiratory Medicine, Bd. 236, 107868
Habler, Katharina; Vogeser, Michael und Teupser, Daniel
(2022):
An UHPLC-MS/MS method for quantification of the CDK4/6 inhibitor abemaciclib in human serum.
In: Journal of Mass Spectrometry and Advances in the Clinical Lab, Bd. 24: S. 15-21
Habler, Katharina; Kalla, Anne-Sophie; Rychlik, Michael; Bruegel, Mathias; Teupser, Daniel; Naehrig, Susanne; Vogeser, Michael und Paal, Michael
(2022):
Isotope dilution LC-MS/MS quantification of the cystic fibrosis transmembrane conductance regulator (CFTR) modulators ivacaftor, lumacaftor, tezacaftor, elexacaftor, and their major metabolites in human serum.
In: Clinical Chemistry and Laboratory Medicine, Bd. 60, Nr. 1: S. 82-91
Habler, Katharina; Brügel, Mathias; Teupser, Daniel; Liebchen, Uwe; Scharf, Christina; Schönermarck, Ulf; Vogeser, Michael und Paal, Michael
(2021):
Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum.
In: Journal of Pharmaceutical and Biomedical Analysis, Bd. 196, 113935
Habler, Katharina; Köppl, Bernhard; Bracher, Franz und Vogeser, Michael
(2021):
Targeted profiling of 24 sulfated and non-sulfated bile acids in urine using two-dimensional isotope dilution UHPLC-MS/MS.
In: Clinical Chemistry and Laboratory Medicine, Bd. 60, Nr. 2: S. 220-228
Paal, Michael; Habler, Katharina und Vogeser, Michael
(2021):
Estimation of inter-laboratory reference change values from external quality assessment data.
In: Biochemia Medica, Bd. 31, Nr. 3, 30902
Paal, Michael; Habler, Katharina und Vogeser, Michael
(2021):
Mass spectrometric sample identification with indicator compounds introduced via labeled sample tubes.
In: Clinical Chemistry and Laboratory Medicine, Bd. 59, Nr. 1: S. 147-154
Schuster, Carina; Habler, Katharina und Vogeser, Michael
(2021):
Effect of gravimetric correction and type of pipettes used in sample preparation on the precision of LC?MS/MS-based analyses.
In: Clinical Biochemistry, Bd. 91: S. 63-66
Schuster, Carina; Habler, Katharina und Vogeser, Michael
(2020):
Averaging of results derived from different, simultaneously acquired mass transitions in ID-LC-MS/MS - Potential impact on measurement imprecision.
In: Clinical Mass Spectrometry, Bd. 17: S. 1-3
Habler, Katharina; Paal, Michael und Vogeser, Michael
(2020):
Isotope dilution-LC-MS/MS method for quantification of the urinary cotinine-to-creatinine ratio.
In: Clinical Chemistry and Laboratory Medicine, Bd. 58, Nr. 9: S. 1469-1476
Paal, Michael; Habler, Katharina; Northoff, Bernd und Vogeser, Michael
(2020):
Comparative Routine Therapeutic Drug Monitoring of Mycophenolic Acid in human Plasma with HPLC-UV and Isotope Dilution LC-MS/MS.
In: Clinical Laboratory, Bd. 66, Nr. 4: S. 613-620